Alta Fundamental Advisers’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.81M | Sell |
454,944
-16,030
| -3% | -$170K | 2.47% | 14 |
|
|
2025
Q1 | $7.08M | Sell |
470,974
-229,458
| -33% | -$3.45M | 4.55% | 9 |
|
|
2024
Q4 | $11.5M | Buy |
700,432
+404,350
| +137% | +$6.66M | 3.45% | 10 |
|
|
2024
Q3 | $7.31M | Hold |
296,082
| – | – | 2.11% | 9 |
|
|
2024
Q2 | $7.5M | Buy |
296,082
+34,700
| +13% | +$879K | 2.38% | 8 |
|
|
2024
Q1 | $6.64M | Buy |
261,382
+68,838
| +36% | +$1.75M | 2.51% | 7 |
|
|
2023
Q4 | $4.36M | Buy |
+192,544
| New | +$4.36M | 1.97% | 7 |
|